Application and progress of artificial intelligence technology in gastric cancer diagnosis and treatment.
10.3760/cma.j.cn441530-20220329-00120
- VernacularTitle:人工智能技术在胃癌诊疗中的应用与进展
- Author:
Wei Qi LIANG
1
;
Tao CHEN
1
;
Jiang YU
1
Author Information
1. Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Cancer, Guangzhou 510515, China.
- Publication Type:Journal Article
- MeSH:
Artificial Intelligence;
Humans;
Machine Learning;
Neural Networks, Computer;
Stomach Neoplasms/therapy*;
Technology
- From:
Chinese Journal of Gastrointestinal Surgery
2022;25(8):741-746
- CountryChina
- Language:Chinese
-
Abstract:
Artificial intelligence (AI) is one of the most rapidly evolving fields in biomedicine during the past decade. Represented by radiomics, machine learning and deep neural network, AI has been increasingly favored by researchers due to its ability to obtain feature information and discover the potential relationship between data and medical outcomes from high-throughput medical data. The incidence and mortality of gastric cancer (GC) has remained high in China. Through combining AI technology with medical examination such as endoscopy, imaging, pathological examination and sequencing, clinical researchers have made great progress in the auxiliary diagnosis, disease staging, prognosis and curative effect prediction of patients with GC. Although the intervention of AI in the medical industry has greatly improved the effective utilization of high-throughput data and accelerated the intelligent process of disease diagnosis and treatment, a number of problems has been raised in medical ethics, patient privacy and the legal status of medical AI at the same time. In the future, rational planning and management of AI technology will provide a strong impetus to promote the development of medicine and reshape the medical industry.
